Ver Investigador - - Prisma - Unidad de Bibliometría

Francisco Jose Marquez Malaver

Profesor Asociado CIS
fmarquez4@us.es
Área de conocimiento: Enfermería
Departamento: Enfermería
Grupo: Sin grupo

Investiga en

Tipo Año Título Fuente
Artículo2024 Incorporation mutational profile might reduce the importance of blast count in prognostication of low-risk myelodysplastic syndromes BRITISH JOURNAL OF HAEMATOLOGY
Resumen congreso2022 SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients with Lower-Risk Myelodysplastic Syndrome BLOOD
Artículo2022 SF3B1, RUNX1 and TP53 mutations significantly impact the outcome of patients with lower-risk myelodysplastic syndrome CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2021 Treatment of steroid-refractory chronic graft-versus-host disease with imatinib: Real-life experience of the Spanish group of hematopoietic transplantation (GETH) CLINICAL TRANSPLANTATION
Artículo2020 Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study BMJ OPEN
Artículo2020 Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP EUROPEAN JOURNAL OF HAEMATOLOGY
Artículo2020 Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation BONE MARROW TRANSPLANTATION
Artículo2020 Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study BONE MARROW TRANSPLANTATION
Resumen congreso2020 WHAT SURVIVAL AND QUALITY OF LIFE HAVE ELDERLY MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB? HAEMATOLOGICA
Artículo2019 Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant Approval BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2019 Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms CLINICAL CANCER RESEARCH
Artículo2018 CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Resumen congreso2018 European Myeloma Network phase I trial on RIC allogeneic transplantation: an optimized program for high risk relapsed myeloma patients BONE MARROW TRANSPLANTATION
Artículo2018 Evaluation of parameters related to the probability of leukemic progression in patients with lower-risk myelodysplastic syndrome CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Resumen congreso2018 RATIO OF ABSOLUTE CIRCULATING LYMPHOCYTES/MONOCYTES AS A PROGNOSTIC FACTOR IN THE DLCL-B TO DIAGNOSIS HAEMATOLOGICA
Resumen congreso2018 RESULTS OF TREATMENT GUIDED BY PET/INTERMEDIATE TAC IN PATIENTS WITH DIAGNOSIS OF LYMPHOMA B DIFFUSE OF LARGE CELLS (LBDCG). EXPERIENCE OF A CENTER HAEMATOLOGICA
Resumen congreso2018 WHAT CAN WE CONCLUDE FROM RUXOLITINIB AFTER MORE THAN 5 YEARS OF EXPERIENCE WITH THE DRUG? HAEMATOLOGICA
Resumen congreso2017 ANAGRELIDE RESPONSE ACCORDING TO THE MOLECULAR PROFILE: SOMETHING TO CONCLUDE ON THE MECHANISM OF ACTION OF THE DRUG IN MYELOPROLIFERATIVE NEOPLASMS (MPN)? HAEMATOLOGICA
Resumen congreso2017 ANALYSIS OF PROGNOSTIC FACTORS IN PATIENTS WITH MYELODISPLASIC SYNDROME SUBJECTED TO ALOGENIC TRANSPLANT OF HEMATOPOYETIC PROGENITORS HAEMATOLOGICA
Resumen congreso2017 Analysis of the incidence and causes of admission in the icu in large cohort of adult patients subjected to hematopoyetic transplantation HAEMATOLOGICA
Resumen congreso2017 ASSESSING PROGNOSIS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES. PARAMETERS RELATED TO THE PROBABILITY OF LEUKEMIC PROGRESSION LEUKEMIA RESEARCH
Resumen congreso2017 Description of Mutational Profile in Patients with Lower-Risk Myelodysplastic Syndromes at the Time of Leukemic Progression BLOOD
Resumen congreso2017 EUROPEAN MYELOMA NETWORK CLINICAL TRIAL PHASE I (ALLO-EMN) OF ALLOGENIC TRANSPLANTATION IN PATIENTS WITH HIGH RISK MULTIPLE MYELOMA (MM) HAEMATOLOGICA
Resumen congreso2017 EXTENT OF REGISTRATION IN PROMISE-EBMT AND GLOBAL RESULTS OF SURVIVAL IN TRANSPLANT OF HEMATOPOIETIC PROGENITORS IN ADULTS IN SPAIN ANALYSIS OF GETH HAEMATOLOGICA
Resumen congreso2017 Improvement of outcome after autologous stem cell transplantation by reduction of infections and SOS/VOD syndrome's related mortality: 28 years single-center experience BONE MARROW TRANSPLANTATION
Resumen congreso2017 INFLUENCE OF THE POLYMORPHISMS OF VITAMIN D RECEPTOR (VDR) IN THE EVOLUTION OF PATIENTS AFTER ALLOGENIC TRANSPLANTATION OF HEMATOPOIETIC PROGENITORS AND THE EFFECT OF POST TRANSPLANTATION ADMINISTERED VITAMIN D HAEMATOLOGICA
Resumen congreso2017 Influence of VDR Polymorphisms on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) within the Alovita Trial. BLOOD
Resumen congreso2017 Prognostic evaluation in patients with low risk myelodysplastic syndrome parameters related to the probability of leukemic progression HAEMATOLOGICA
Resumen congreso2017 Similar Probabilities of Failure to Reach Transplantation and Transplant Outcomes after HLA-Identical Sibling or Unrelated Donor Transplant in Patients with Acute Myeloid Leukemia: A Single Institution Evaluation of a Donor Selection Algorithm BLOOD
Resumen congreso2017 THE 1RC STATUS AND THE NEW DIAGNOSIS ARE ASSOCIATED WITH BETTER LONG-TERM SURVIVAL IN ALLOTRANSPLANTED PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA HAEMATOLOGICA
Artículo2017 The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome LEUKEMIA & LYMPHOMA
Resumen congreso2017 THE PROBABILITY OF CONCLUDING ALLOGENIC TRANSPLANTATION FROM ITS INDICATION IS SIMILAR TO HAVING OR NOT HAVING HISTOCOMPATIBLE SIBLING: SELECTION STRATEGY BASED ON THE PREFERENTIAL USE OF UNRELATED DONOR (ND) AS AN ALTERNATIVE SOURCE OF HAEMATOPOIETIC PROGENITORS (HP) HAEMATOLOGICA
Resumen congreso2017 THROMBOTIC MICROANGIOPATHY AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: IS THERE A PROTECTIVE ROLE FOR URSODEOXYCHOLIC ACID? HAEMATOLOGICA
Letter2016 Differences in stem cell transplantation activity among regions in Spain: an economic explanation BONE MARROW TRANSPLANTATION
Artículo2016 Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Letter2016 GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study BONE MARROW TRANSPLANTATION
Artículo2016 Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial CLINICAL CANCER RESEARCH
Resumen congreso2016 IMPLICATION OF THE PERCENTAGE OF MACROPHAGES WITH HAEMOPHAGOCYTOSIS IN THE DIAGNOSIS AND PROGNOSIS OF PATIENTS WITH HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HAEMATOLOGICA
Resumen congreso2016 Multicenter and Retrospective study for Risk factors affecting DLCOc prior Allogeneic Hematopoietic Stem Cell Transplant BONE MARROW TRANSPLANTATION
Letter2016 Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION
Resumen congreso2016 PROGNOSIS FACTORS CONDITIONING THE RISK OF MIELOFIBROTIC TRANSFORMATION IN ESSENTIAL THROMBOCYTHEMIA: SIGNIFICANCE OF ALLELIC BURDEN AND THE NUMBER OF LEUCOCYTES AT DIAGNOSIS IN YOUNG PATIENTS HAEMATOLOGICA
Resumen congreso2016 THE INCORPORATION OF COMORBIDITIES IN THE PROGNOSTICATION OF PATIENTS WITH LOWER-RISK MDS HAEMATOLOGICA
Resumen congreso2015 After admission to intensive care unit non-transplant patients with haematologic malignancies have better survival outcome than recipients of haematopoietic stem cell transplantation HAEMATOLOGICA
Resumen congreso2015 Analysis of factors affecting pre transplant pulmonary function tests and impact on overall Survival after allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION
Resumen congreso2015 Characteristics of oncohematological patients admitted in the intensive care unit (uci): comparision between the patients subjected to transplant of hematopoietic progenitors and non transplantation (no-tph) HAEMATOLOGICA
Resumen congreso2015 COMPARISON OF TREATMENT REGIMENS OF REDUCED INTENSITY CONDITIONING IN ALLOGENIC TRANSPLANT OF HEMATOPOIETIC PROGENITORS FOR LYMPHOMA HAEMATOLOGICA
Artículo2015 Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time BONE MARROW TRANSPLANTATION
Artículo2015 GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT BONE MARROW TRANSPLANTATION
Ponencia2015 IMMUNOMODULATORY EFFECT OF VITAMIN D AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT): RESULTS OF A PROSPECTIVE MULTICENTER CLINICALTRIAL.ALOVITA; EUDRACT: 2010-023279-25 HAEMATOLOGICA
Resumen congreso2015 MISMATCH ON GLUTATHIONE S-TRANSFERASE T1 INCREASES THE RISK OF GRAFT-VERSUS-HOST DISEASE AND MORTALITY AFTER ALLOGENEIC STEM CELL TRANSPLANTATION TISSUE ANTIGENS
Artículo2015 Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score LEUKEMIA RESEARCH
Artículo2015 Overexpression of GYS1, MIF, and MYC Is Associated With Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid Leukemia CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Resumen congreso2015 PROGNOSTIC VALUE OF THE EVALUATION OF THE PRETRANSPLANT ALLOGENEIC CARDIAC FUNCTION HAEMATOLOGICA
Resumen congreso2015 Pronostic Value of Pretransplant Echocardiography in Allogeneic Hematopoietic Cell Transplantation BLOOD
Resumen congreso2015 Results of Allogeneic Transplantation As First Line Rescue Therapy in Patients with Multiple Myeloma Relapsing to a Prior Autograft: Role of Conditioning Regimen BLOOD
Resumen congreso2015 RETROSPECTIVE STUDY OF AZACITIDINE IN PATIENTS OF ADVANCED AGE WITH ACUTE MYELOID LEUKEMIA (LMA). RESULTS OF THE ALMA/ PETHEMA COHORT IN COMPARISON WITH THE MRC RISK INDEX SCORE HAEMATOLOGICA
Artículo2015 Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: Results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH) TRANSPLANT INFECTIOUS DISEASE
Resumen congreso2015 THE ADDITION OF COMORBIDITY ALLOWS A BETTER STRATIFICATION AND DEVELOPMENT OF A SPECIFIC PROGNOSTIC SCORE IN THE GROUP OF PATIENTS WITH MYELODYSPLASTIC SYNDROME OF LOW RISK BY IPSS HAEMATOLOGICA
Resumen congreso2015 THE URSODEOXYCHOLIC DIMINISHES THE RISK OF THROMBOTIC MICROANGIOPATHY AFTER TRANSPLANT OF HEMATOPOIETIC PROGENITORS HAEMATOLOGICA
Resumen congreso2015 The Use of Busulphan As Compared to Melphalan in Combination with Fludarabine in the Reduced Intensity Conditioning Improves Overall Survival in Patients with Lymphoma BLOOD
Resumen congreso2014 AZACITIDINE IMPROVES SURVIVAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES WITH 20-30% BONE MARROW BLASTS AND POOR-RISK CYTOGENETIC CATEGOR HAEMATOLOGICA
Resumen congreso2014 JAK2 V617F ALLELE BURDEN LESS THAN 20% HAS NO INFLUENCE ON OUTCOME OF PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA HAEMATOLOGICA
Artículo2014 Mismatch on Glutathione S-Transferase T1 Increases the Risk of Graft-versus-Host Disease and Mortality after Allogeneic Stem Cell Transplantation BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2014 Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Resumen congreso2014 Role of PET/CT Assesment before Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma Patients BLOOD
Resumen congreso2014 Strategies for Graft Versus Host Disease Prophylaxis after Reduced-Intensity Conditioning Transplantation: Combination of Sirolimus Plus Tacrolimus Allows to Obtain the Best Outcome BLOOD
Resumen congreso2013 Azacitidine Alone Or The Combination With Valproic Acid As a Bridge Therapy For Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes Before Transplantation BLOOD
Artículo2013 Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic Categories CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Resumen congreso2013 Higher-risk myelodysplastic syndromes. Does the severity of cytopenias at diagnosis have any prognostic significance? LEUKEMIA RESEARCH
Artículo2013 Improvement over the years of long-term survival in high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy TRANSPLANTATION PROCEEDINGS
Resumen congreso2013 Multivariable Time-Dependent Analysis Of The Impact Of 5 Azacitidine In Patients With Lower-Risk Myelodysplastic Syndrome and Unfavorable Specific Lower-Risk Score BLOOD
Ponencia2013 Onco-haematologic patients' sexuality. What do you do? What do you know about it? BONE MARROW TRANSPLANTATION
Resumen congreso2013 Patterns of infection in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) receiving 5-azacitidine. Candidates for antifungal prophylaxis LEUKEMIA RESEARCH
Artículo2013 The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate HAEMATOLOGICA
Artículo2013 To freeze or not to freeze peripheral blood stem cells prior to allogeneic transplantation from matched related donors EUROPEAN JOURNAL OF HAEMATOLOGY
Artículo2012 A constitutional variant in the transcription factor EP300 strongly influences the clinical outcome of patients submitted to allo-SCT BONE MARROW TRANSPLANTATION
Resumen congreso2012 Clinical prognostic factors for myelodysplastic syndromes presenting non-unfavourable cytogenetic categories according to IPSS and the new cytogenetic prognostic scoring system HAEMATOLOGICA
Resumen congreso2012 Patterns of Infection in Patients with Myeloid Malignancies Receiving 5-Azacytidine: identification of Candidates for Antifungal Prophylaxis BLOOD
Resumen congreso2012 To freeze or not to freeze haematopoietic stem cells prior to allogeneic transplantation BONE MARROW TRANSPLANTATION
Resumen congreso2011 A new nursing intervention in NIC taxonomy: infusion of haematopoietic stem cells BONE MARROW TRANSPLANTATION
Resumen congreso2010 Constitutional variability in genes involved in innate immunity (IRF-3, HAMP, PTX3) and in cell proliferation (ATBF1 and NFAT5) influences disease free survival after allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION
Resumen congreso2010 CONSTITUTIONAL VARIABILITY IN GENES INVOLVED IN INNATE IMMUNITY AND IN CELL PROLIFERATION INFLUENCES DISEASE FREE SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION HAEMATOLOGICA
Resumen congreso2010 Genetic Variability In the Transcriptional Factor EP300 Strongly Influences the Clinical Outcome of Allogeneic Stem Cell Transplantation (Allo-SCT) BLOOD
Resumen congreso2010 How organizational pre-transplant measures may improve clinical outcomes in haemopoietic stem cell transplantation BONE MARROW TRANSPLANTATION
Resumen congreso2010 Minimal residual disease post-consolidation therapy affects outcome after stem cell transplantation in acute myeloid leukaemia BONE MARROW TRANSPLANTATION
Resumen congreso2010 Retrospective analysis of second haematopoietic stem cell transplant. Single-centre experience BONE MARROW TRANSPLANTATION
Artículo2010 Role of Second Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Hematologic Malignancies TRANSPLANTATION PROCEEDINGS
Resumen congreso2009 Hickman catheter-associated infections after haematopoietic stem cell transplantation and their relationship with period elapsing from catheter implantation to transplantation BONE MARROW TRANSPLANTATION
Resumen congreso2009 Reasons why acute leukaemia patients with established indication for stem cell transplantation do not finally undergo the procedure and its clinical consequences BONE MARROW TRANSPLANTATION
Artículo2008 Evaluation of the Pretransplantation Phase of the Hemopoietic Stem Cell Program in a Tertiary Hospital TRANSPLANTATION PROCEEDINGS
Artículo2008 High Rate of Long-Term Survival for High-Risk Lymphoma Patients Treated With Hematopoietic Stem Cell Transplantation as Consolidation or Salvage Therapy TRANSPLANTATION PROCEEDINGS
Resumen congreso2008 The efficacy of a single dose pegfilgrastim following myeloablative chemotherapy for stem cell mobilisation in patients with solid tumours and lymphomas BONE MARROW TRANSPLANTATION
Resumen congreso2008 The role of reduced-intensity allogeneic stem cell transplantation in patients with advanced acute myeloid leukaemia and myelodysplastic syndromes BONE MARROW TRANSPLANTATION
Resumen congreso2007 Comprehensive view of the haemopoietic stem cell program: The pre-transplant phase HAEMATOLOGICA
Resumen congreso2007 The role of allogeneic stem cell transplantation with reduced-intensity conditioning in patients with chemoresistant malignancies BONE MARROW TRANSPLANTATION
Artículo2006 Evaluation of readmissions in hematopoietic stem cell transplant recipients TRANSPLANTATION PROCEEDINGS
Resumen congreso2006 Readmissions evaluation in allogeneic haematopoietic stem cell transplant recipients BONE MARROW TRANSPLANTATION
Resumen congreso2006 Risk for infection;: a daily battle against germs BONE MARROW TRANSPLANTATION
Este investigador no ha dirigido/tutorizado tesis
El investigador no tiene ningún proyecto asociado.
El investigador no tiene ningún resultado de investigación asociado